Monitor The Insider Activity Of Prothena Corporation plc (PRTA)

BEPC Stock
BEPC Stock

As of Wednesday close, Prothena Corporation plc’s (NASDAQ:PRTA) stock was up $1.13, moving up 1.86 percent to $61.95. The average number of shares traded per day over the past five days has been 392,960 shares. 4 times new highs have been achieved over the past 5 days, with a $3.37 gain in that time frame. In the last twenty days, the average volume was 567,075, while in the previous 50 days, it was 909,266.

Since last month, PRTA stock rose 2.65%. Shares of the company fell to $51.96 on 11/09/22, the lowest level in the past month. A 52-week high of $65.35 was reached on 11/01/22 after having rallying from a 52-week low of $21.06. Since the beginning of this year, PRTA’s stock price has risen by 25.40% or $12.55, and marked a new high 5 times. However, the stock has declined by -5.20% since its 52-week high.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


PRTA stock investors should be aware that Prothena Corporation plc (PRTA) stock had its last reported insider trading activity 6 days ago on Nov 18. Walker Karin L, the Chief Accounting Officer of the company, disposed of 10,000 shares for $57.07 on Nov 18. It resulted in a $570,709 divestment by the insider. Cooke Shane sold 5,000 shares at an average price of $56.17 on Nov 10. The insider now owns 0 shares following the transaction. On Nov 07, Director COLLIER RICHARD T sold 5,000 shares at $55.62 apiece. The transaction was valued at $278,083.

Valuation Metrics

The stock’s beta is 0.50. Besides these, the trailing price-to-sales (P/S) ratio of 563.75, the price-to-book (PB) ratio of 7.20.

Financial Health

In the three months ended June 29, Prothena Corporation plc’s quick ratio stood at 10.40, while its current ratio was 10.40, showing that the company is able to pay off its debt. Based on annual data, PRTA earned $128.6 million in gross profit and brought in $200.58 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 14.40%. Return on equity (ROE) for the past 12 months was -36.50%.

According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. PRTA’s revenue fell -9055.92% to $1.31 million during the quarter, while net income inched up to $1.52 million. While analysts expected Prothena Corporation plc to report -$0.52 quarterly earnings, the actual figure was -$0.88 per share, beating the consensus estimate by -69.20%. During the quarter, the company generated -$48.62 million in EBITDA. The liabilities of Prothena Corporation plc were 149.79 million at the end of its most recent quarter ended June 29, and its total debt was $9.58 million. The value of shareholders’ equity is $48.38 million.

Technical Picture

This quick technical analysis looks at Prothena Corporation plc’s (PRTA) price momentum. With a historical volatility rate of 54.34%, the RSI 9-day stood at 60.64% on 23 November.

With respect to its five-day moving average, the current Prothena Corporation plc price is up by +5.75% percent or $3.37. At present, PRTA shares trade +2.77% above its 20-day simple moving average and +108.66% percent above its 100-day simple moving average. However, the stock is currently trading approximately +110.93% above its SMA50 and +78.07% above its SMA200.

Stochastic coefficient K was 74.42% and Stochastic coefficient D was 62.17%, while ATR was 3.59. Given the Stochastic reading of 82.70% for the 14-day period, the RSI (14) reading has been calculated as 59.28%. As of today, the MACD Oscillator reading stands at 1.36, while the 14-day reading stands at 2.97.

Analyst Ratings

Prothena Corporation plc downgraded its rating on Prothena Corporation plc (NASDAQ: PRTA) to a Sector perform in a note to investors on November 04, 2022. The analysts firm previously had an Outperform rating on the stock.Prothena Corporation plc (PRTA) has been rated Buy by analysts. According to 0 brokerage firms, PRTA is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Prothena Corporation plc stock as buy, with 8 recommending it as overweight.

With a median target price of $76.00, the current consensus forecast for the stock is $55.00 – $120.00. Based on these forecasts, analysts predict Prothena Corporation plc (PRTA) will achieve an average price target of $80.89.


Please enter your comment!
Please enter your name here